Profile data is unavailable for this security.
About the company
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
- Revenue in USD (TTM)82.49m
- Net income in USD-114.84m
- Incorporated2000
- Employees401.00
- LocationPacific Biosciences of California Inc1305 O'brien DriveMENLO PARK 94025United StatesUSA
- Phone+1 (650) 521-8000
- Fax+1 (302) 636-5454
- Websitehttps://www.pacb.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs Holdings Inc | 81.71m | -43.11m | 516.87m | 505.00 | -- | 11.78 | -- | 6.33 | -2.10 | -2.10 | 3.99 | 2.13 | 0.6817 | 1.60 | 4.06 | 161,807.90 | -35.96 | -- | -42.15 | -- | 59.20 | -- | -52.76 | -- | 3.52 | -5.84 | 0.5235 | -- | 76.49 | -- | 39.54 | -- | -- | -- |
| Cutera, Inc. | 175.39m | -36.55m | 533.33m | 402.00 | -- | 12.10 | -- | 3.04 | -2.62 | -2.62 | 12.42 | 3.10 | 1.52 | 2.67 | 7.21 | 436,283.60 | -31.76 | -1.21 | -56.35 | -1.75 | 50.27 | 54.91 | -20.84 | -0.9835 | 1.05 | -70.39 | 0.0279 | -- | 7.41 | 16.88 | -182.51 | -- | 23.54 | -- |
| Viewray Inc | 91.98m | -101.73m | 566.64m | 221.00 | -- | 3.70 | -- | 6.16 | -1.05 | -1.05 | 0.9451 | 1.09 | 0.3412 | 1.68 | 3.29 | 416,181.00 | -37.74 | -63.61 | -46.06 | -109.53 | -1.03 | 1.56 | -110.60 | -180.49 | 2.49 | -31.84 | 0.3396 | -- | 137.83 | 91.31 | -9.63 | -- | 16.76 | -- |
| SurModics, Inc. | 100.08m | 7.59m | 569.87m | 369.00 | 76.35 | 4.64 | 38.24 | 5.69 | 0.5509 | 0.5509 | 7.26 | 9.07 | 0.6178 | 3.20 | 7.67 | 271,211.40 | 4.69 | 4.60 | 5.65 | 5.16 | 86.37 | 84.89 | 7.59 | 7.89 | 3.81 | -- | 0.00 | 0.00 | 23.04 | 11.74 | 365.73 | -9.06 | 24.26 | -- |
| AngioDynamics, Inc. | 251.34m | -11.95m | 579.72m | 750.00 | -- | 0.9534 | 42.83 | 2.31 | -0.3185 | 1.62 | 6.63 | 16.16 | 0.3631 | 2.14 | 6.91 | 239,367.60 | -1.73 | -2.11 | -1.85 | -2.31 | 59.58 | 52.49 | -4.76 | -5.21 | 2.57 | 0.3561 | 0.00 | -- | 3.43 | -5.25 | 18.21 | -- | -24.38 | -- |
| Orthopediatrics Corp | 68.17m | -10.82m | 587.31m | 80.00 | -- | 6.82 | -- | 8.62 | -0.7665 | -0.763 | 4.83 | 5.75 | 0.592 | 0.5694 | 5.77 | 852,100.00 | -9.40 | -- | -12.50 | -- | 74.35 | -- | -15.88 | -- | 1.61 | -2.59 | 0.373 | -- | 26.17 | -- | 48.90 | -- | -- | -- |
| AxoGen Inc | 101.98m | -27.33m | 657.94m | 278.00 | -- | 4.86 | -- | 6.45 | -0.6999 | -0.6999 | 2.61 | 3.43 | 0.6458 | 1.47 | 6.93 | 366,843.50 | -17.30 | -31.05 | -19.04 | -36.64 | 82.21 | 81.92 | -26.80 | -34.11 | 7.38 | -- | 0.0004 | -- | 38.91 | 50.29 | -114.42 | -- | 93.41 | -- |
| Intersect ENT Inc | 110.17m | -40.07m | 665.28m | 393.00 | -- | 6.00 | -- | 6.04 | -1.28 | -1.28 | 3.54 | 3.52 | 0.8223 | 1.49 | 7.97 | 280,333.30 | -29.91 | -19.77 | -34.68 | -22.45 | 81.00 | 80.81 | -36.37 | -28.54 | 5.49 | -- | 0.00 | -- | 12.64 | 43.33 | -40.08 | -- | 35.28 | -- |
| LeMaitre Vascular Inc | 115.45m | 19.35m | 698.30m | 457.00 | 36.58 | 5.15 | 28.46 | 6.05 | 0.955 | 0.955 | 5.70 | 6.78 | 0.7346 | 1.33 | 8.28 | 252,628.00 | 12.31 | 12.02 | 13.80 | 13.59 | 68.57 | 69.70 | 16.76 | 13.84 | 3.49 | -- | 0.00 | 29.39 | 4.66 | 10.34 | 34.37 | 47.75 | 1.06 | 18.17 |
| Axonics Modulation Technologies Inc | 4.37m | -66.85m | 730.23m | 87.00 | -- | 7.93 | -- | 167.18 | -2.39 | -2.39 | 0.1565 | 3.22 | 0.0519 | 0.2959 | 7.45 | 50,206.90 | -79.41 | -- | -115.00 | -- | 49.70 | -- | -1,530.43 | -- | 6.76 | -- | 0.2155 | -- | 451.83 | -- | -79.85 | -- | -- | -- |
| Pacific Biosciences of California | 82.49m | -114.84m | 765.17m | 401.00 | -- | 15.00 | -- | 9.28 | -0.7579 | -0.7579 | 0.544 | 0.3334 | 0.5014 | 3.17 | 10.08 | 205,703.20 | -69.81 | -53.12 | -89.48 | -68.72 | 33.21 | 43.43 | -139.22 | -88.18 | 1.22 | -44.22 | 0.2336 | -- | -15.88 | 22.78 | -11.25 | -- | 15.32 | -- |
| Antares Pharma Inc | 104.85m | -588.00k | 798.18m | 165.00 | -- | 17.97 | 355.69 | 7.61 | -0.0033 | -0.0033 | 0.6451 | 0.2721 | 1.06 | 3.32 | 3.75 | 635,430.30 | -0.5955 | -27.03 | -0.848 | -36.39 | 56.05 | 51.31 | -0.5608 | -42.65 | 2.46 | -3.23 | 0.4755 | -- | 16.58 | 25.25 | 61.09 | -- | -22.33 | -- |
| Lantheus Holdings Inc | 344.26m | 34.51m | 802.23m | 488.00 | 23.61 | 7.93 | 16.81 | 2.33 | 0.8656 | 0.8656 | 8.61 | 2.58 | 0.8323 | 5.22 | 7.84 | 705,454.90 | 8.34 | 5.90 | 9.68 | 6.98 | 50.57 | 46.82 | 10.02 | 5.54 | 2.08 | 3.54 | 0.6602 | 0.00 | 3.62 | 3.89 | 6.39 | -- | 32.07 | -- |
| MiMedx Group Inc | 303.47m | 35.33m | 820.68m | 690.00 | 24.39 | 5.77 | 20.00 | 2.70 | 0.3038 | 0.3038 | 2.63 | 1.28 | 1.68 | 2.49 | 4.93 | 439,808.70 | 19.61 | 7.55 | 24.92 | 9.25 | 88.19 | 87.47 | 11.64 | 5.63 | 2.95 | 73.83 | 0.00006 | 0.00 | 30.82 | 99.46 | -59.34 | -- | 71.02 | -- |
| Orthofix Medical Inc | 459.54m | -31.35m | 882.44m | 954.00 | -- | 2.85 | -- | 1.92 | -1.66 | -1.65 | 24.17 | 16.23 | 0.9928 | 1.24 | 5.97 | 481,697.10 | -6.77 | 1.31 | -8.24 | 1.62 | 78.23 | 77.91 | -6.82 | 1.26 | 1.77 | -- | 0.0643 | 0.00 | 4.43 | 2.64 | -15.26 | -- | -10.86 | -- |
| Cryolife Inc | 274.32m | 1.38m | 936.09m | 1.10k | 707.48 | 3.37 | 49.00 | 3.41 | 0.0353 | 0.0418 | 7.39 | 7.40 | 0.472 | 1.96 | 5.52 | 249,385.50 | 0.2387 | 1.37 | 0.2547 | 1.50 | 66.22 | 65.25 | 0.5056 | 2.43 | 3.15 | 1.29 | 0.4441 | 30.49 | 38.55 | 13.30 | -190.11 | -- | 5.93 | -- |
Data as of Dec 09 2019. Currency figures normalised to Pacific Biosciences of California Inc's reporting currency: US Dollar USD
37.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2019 | 10.25m | 6.70% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 7.51m | 4.91% |
| Magnetar Financial LLCas of 30 Sep 2019 | 7.07m | 4.62% |
| CNH Partners LLCas of 30 Sep 2019 | 6.87m | 4.49% |
| Alpine Associates Management, Inc.as of 30 Sep 2019 | 5.50m | 3.60% |
| ARP Americas LPas of 30 Sep 2019 | 5.37m | 3.51% |
| Water Island Capital LLCas of 30 Sep 2019 | 4.59m | 3.00% |
| ArrowMark Colorado Holdings LLCas of 30 Sep 2019 | 3.46m | 2.26% |
| Goldman Sachs & Co. LLC (Private Banking)as of 30 Sep 2019 | 3.14m | 2.05% |
| SSgA Funds Management, Inc.as of 30 Sep 2019 | 2.98m | 1.95% |
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
